• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大动脉炎相关难治性高血压通过肾小球微血管病变诱发肾病综合征。

Takayasu arteritis-associated refractory hypertension induces nephrotic syndrome through glomerular microangiopathy.

作者信息

Nakayamada Tomoya, Taguchi Kensei, Natori Chikei, Nakamura Nao, Fujii Makiko, Yamashita Yuya, Ito Sakuya, Fukami Kei

机构信息

Division of Nephrology, Department of Medicine, Kurume University School of Medicine, 67 Asahi-Machi, Kurume, 830-0011, Japan.

Research Institute of Medical Mass Spectrometry, Kurume University School of Medicine, Kurume, 830-0011, Japan.

出版信息

CEN Case Rep. 2024 Dec 9. doi: 10.1007/s13730-024-00952-5.

DOI:10.1007/s13730-024-00952-5
PMID:39648265
Abstract

Takayasu arteritis (TAK) is a systemic inflammatory condition characterized by vasculitis in mainly the aorta and their branches; however, few reports have demonstrated glomerulonephritis and subsequent nephrotic syndrome in patients with TAK. We encountered a 69-year-old woman with TAK who developed nephrotic syndrome owing to uncontrolled hypertension. Kidney biopsy demonstrated endotheliosis, aberrant proliferation of vascular smooth muscle cells, and concentric intimal hyperplasia without any clues of vasculitis. Treatment with sacubitril/valsartan reduced proteinuria and increased serum albumin without affecting renal function, which continued to suppress blood pressure and prevent recurrence of nephrotic syndrome over 2 years.

摘要

高安动脉炎(TAK)是一种全身性炎症性疾病,主要特征是主动脉及其分支的血管炎;然而,很少有报道显示TAK患者出现肾小球肾炎及随后的肾病综合征。我们遇到一名69岁的TAK女性患者,她因高血压控制不佳而发展为肾病综合征。肾活检显示内皮细胞增生、血管平滑肌细胞异常增殖和同心性内膜增生,无任何血管炎迹象。使用沙库巴曲缬沙坦治疗可减少蛋白尿并增加血清白蛋白,且不影响肾功能,在2年多的时间里持续抑制血压并预防肾病综合征复发。

相似文献

1
Takayasu arteritis-associated refractory hypertension induces nephrotic syndrome through glomerular microangiopathy.大动脉炎相关难治性高血压通过肾小球微血管病变诱发肾病综合征。
CEN Case Rep. 2024 Dec 9. doi: 10.1007/s13730-024-00952-5.
2
Effects of Sacubitril/Valsartan on Blood Pressure and Proteinuria in Hypertensive Patients With Chronic Kidney Disease.沙库巴曲缬沙坦对慢性肾脏病高血压患者血压和蛋白尿的影响。
J Clin Hypertens (Greenwich). 2025 Jul;27(7):e70089. doi: 10.1111/jch.70089.
3
Frequency and the effects of spondyloarthritis-spectrum disorders on the clinical course and management of Takayasu arteritis: an observational retrospective study.脊柱关节炎谱系障碍在高安动脉炎临床病程及管理中的频率和影响:一项观察性回顾研究
Clin Rheumatol. 2024 May;43(5):1571-1578. doi: 10.1007/s10067-024-06939-y. Epub 2024 Apr 2.
4
Case Report: Can early full-course tocilizumab therapy reverse vascular stenosis in Takayasu arteritis?病例报告:早期全程使用托珠单抗治疗能否逆转大动脉炎的血管狭窄?
Front Immunol. 2025 Jun 26;16:1593770. doi: 10.3389/fimmu.2025.1593770. eCollection 2025.
5
Immunosuppressive treatment for primary membranous nephropathy in adults with nephrotic syndrome.成人肾病综合征中原发性膜性肾病的免疫抑制治疗。
Cochrane Database Syst Rev. 2021 Nov 15;11(11):CD004293. doi: 10.1002/14651858.CD004293.pub4.
6
Cardiac Insights in Takayasu's Arteritis: Echocardiographic Differences in Active Takayasu Arteritis.大动脉炎的心脏洞察:活动期大动脉炎的超声心动图差异
Echocardiography. 2025 Jun;42(6):e70229. doi: 10.1111/echo.70229.
7
Corticosteroid therapy for nephrotic syndrome in children.儿童肾病综合征的皮质类固醇治疗
Cochrane Database Syst Rev. 2004(2):CD001533. doi: 10.1002/14651858.CD001533.pub2.
8
Corticosteroid therapy for nephrotic syndrome in children.儿童肾病综合征的皮质类固醇治疗
Cochrane Database Syst Rev. 2003(1):CD001533. doi: 10.1002/14651858.CD001533.
9
Nephrotic syndrome induced by aortic regurgitation with Takayasu arteritis: an autopsy case with long-term clinical follow-up.由主动脉瓣反流伴多发性大动脉炎引起的肾病综合征:一例长期临床随访的尸检病例。
CEN Case Rep. 2024 Jun;13(3):154-160. doi: 10.1007/s13730-023-00819-1. Epub 2023 Sep 22.
10
[A "pulseless" woman with proteinuria!].[一位患有蛋白尿的“无脉”女性!]
Ann Biol Clin (Paris). 2004 Jul-Aug;62(4):441-5.

本文引用的文献

1
Hypertension-Induced Thrombotic Microangiopathy Leading to End-Stage Renal Disease.高血压诱导的血栓性微血管病导致终末期肾病
Cureus. 2023 Jan 17;15(1):e33890. doi: 10.7759/cureus.33890. eCollection 2023 Jan.
2
Renal Thrombotic Microangiopathy: A Review.肾血栓性微血管病:综述。
Am J Kidney Dis. 2023 May;81(5):591-605. doi: 10.1053/j.ajkd.2022.10.014. Epub 2022 Dec 10.
3
The effect of Sacubitril/Valsartan on cardiac function and cardiac remodeling in patients with heart failure with reduced ejection fraction.沙库巴曲缬沙坦对射血分数降低的心力衰竭患者心功能和心脏重构的影响。
Ann Palliat Med. 2021 Aug;10(8):8684-8691. doi: 10.21037/apm-21-157.
4
Angiotensin receptor-neprilysin inhibitors: Comprehensive review and implications in hypertension treatment.血管紧张素受体-脑啡肽酶抑制剂:全面综述及其在高血压治疗中的意义。
Hypertens Res. 2021 Oct;44(10):1239-1250. doi: 10.1038/s41440-021-00706-1. Epub 2021 Jul 21.
5
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis.2021 年美国风湿病学会/血管炎基金会巨细胞动脉炎和 Takayasu 动脉炎管理指南。
Arthritis Care Res (Hoboken). 2021 Aug;73(8):1071-1087. doi: 10.1002/acr.24632. Epub 2021 Jul 8.
6
Bevacizumab-associated glomerular microangiopathy that occurred after postoperative chemotherapy for ovarian cancer.贝伐珠单抗相关性肾小球微血管病,发生于卵巢癌术后化疗之后。
CEN Case Rep. 2021 Feb;10(1):6-11. doi: 10.1007/s13730-020-00504-7. Epub 2020 Jul 8.
7
Natriuretic peptides and neprilysin inhibition in hypertension and hypertensive organ damage.利钠肽与中性肽链内切酶抑制在高血压及高血压性器官损害中的作用
Peptides. 2020 Oct;132:170352. doi: 10.1016/j.peptides.2020.170352. Epub 2020 Jun 28.
8
Impact of Sacubitril-Valsartan on Markers of Glomerular Function.沙库巴曲缬沙坦对肾小球功能标志物的影响。
Curr Heart Fail Rep. 2020 Aug;17(4):145-152. doi: 10.1007/s11897-020-00463-1.
9
Natriuretic Peptides in the Cardiovascular System: Multifaceted Roles in Physiology, Pathology and Therapeutics.心血管系统中的利钠肽:在生理学、病理学和治疗学中的多方面作用。
Int J Mol Sci. 2019 Aug 16;20(16):3991. doi: 10.3390/ijms20163991.
10
2018 Update of the EULAR recommendations for the management of large vessel vasculitis.2018 年版 EULAR 大血管血管炎管理建议更新。
Ann Rheum Dis. 2020 Jan;79(1):19-30. doi: 10.1136/annrheumdis-2019-215672. Epub 2019 Jul 3.